Countries including Bulgaria, Czech Republic, Hungary, Poland, Romania, Russia, Turkey, and Ukraine are expected to witness considerable growth through 2012 because of low cost advantages and the ease with which they can recruit from an abundant heterogenous patient population.While it is clear that many options exist globally to satisfy the growing demand for clinical trials, cost-effective oppor